Active substance
Penicillin g procaine
- US FDA 6
- Safety 2
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| PENICILLIN G PROCAINE | 600,000 UNITS/ML; 300,000 UNITS/ML | injectable · injection | KING PHARMS LLC | Prescription | 26 Apr 1948 |
| PENICILLIN G PROCAINE | 300,000 UNITS/VIAL; 1,500,000 UNITS/VIAL | injectable · injection | PFIZER | Discontinued | 10 Nov 1948 |
| PFIZERPEN-AS | 300,000 UNITS/ML; 600,000 UNITS/ML | injectable · injection | PFIZER | Discontinued | 1 Nov 1950 |
| DURACILLIN A.S. | 300,000 UNITS/ML | injectable · injection | LILLY | Discontinued | |
| PENICILLIN G PROCAINE | 300,000 UNITS/ML; 600,000 UNITS/1.2ML | injectable · injection | CONSOLIDATED PHARM | Discontinued | |
| PENICILLIN G PROCAINE | 300,000 UNITS/ML | injectable · injection | PARKE DAVIS | Discontinued |
Safety signals and safety-related labeling changes
- US FDA 25 Jun 2026 BICILLIN C-R — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions - US FDA 25 Jun 2026 BICILLIN C-R 900/300 — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.